Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Ophthalmic devices ‐ other - Notified Body 0123 - 12/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Ophthalmic devices ‐ other - Notified Body 0123 - 12/01/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Resorbable filling and reconstruction devices - Notified Body 2797 - 08/05/2026 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Resorbable filling and reconstruction devices - Notified Body 2797 - 08/05/2026 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness